News Focus
News Focus
Followers 35
Posts 2238
Boards Moderated 0
Alias Born 10/18/2019

Re: FeMike post# 514317

Friday, 09/16/2022 1:00:03 PM

Friday, September 16, 2022 1:00:03 PM

Post# of 823927
FeMike, imo that is why one of the secondary endpoints on the European sites is evaluating confirmed progression within the trial patients. From the data presented so far imo there is no way to say pfs was a succes. Now I agree we need more data but from slide #11 of the NYAS presentation 11% (26 of 232) of those on treatment did not progress vs 13% 13 of 99) of placebos. We need more data on pseudoprogressors to make a real determination but at this point can't claim pfs a success. For OS can claim a success
I am very interested to see all the data and seems to be taking a very long time
Hope they are working very very very hard
Pedal to the metal

Also wonder how large and long a task it is to complete a bla and similar for the UK and Europe. Remember the SAP was a 'ginormous' task and took a year or more
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News